Validation of the French Version of the New Mobility Score (NMS)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Questionnaires.
- Who it may be relevant to
- Registry conditions: Hip Fractures, Mobility Limitation, Independence, Autonomy. Basic parameters: from 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Validation of the French Version of the New Mobility Score (NMS) in Hospitalized Patients With Hip Fracture
Overview
The incidence of hip fractures in France is 50,000 cases per year among women and 16,000 among men, with a 1-year mortality rate of 20-24%. After a fracture, 10-30% of patients become functionally dependent. The increasing aging of the population and the rise in dependency are likely to worsen the situation of older patients in hospital settings. Several tools are available to assess functional independence, including the New Mobility Score (NMS), which evaluates mobility through three domains: mobility indoors, mobility outdoors, and shopping activities. The NMS has shown good performance in predicting patient mortality and functional recovery, and its use is recommended in clinical practice. However, the French version of the NMS has not yet been validated. The French validation of the NMS is important to facilitate its implementation in clinical practice and research, particularly because of its simplicity and the need for rapid assessment tools for healthcare professionals. A French version of the NMS has been translated, and the MOB-SCORE study aims to assess its reliability and validity among healthcare professionals caring for patients with hip fractures.
Interventions
- Other Questionnaires
New Mobility Score (NMS), Measure of Functional Independence (MIF), Cumulated Ambulation Score (CAS), Mini-Mental State Examination (MMSE).
Primary outcome measures
- Inter-rater reliability of the New Mobility Score (NMS) [Time frame: Within 7 days following the fracture surgery]
Secondary outcome measures (4)
- Internal consistency of the New Mobility Score (NMS) [Time frame: Within 7 days following the fracture surgery]
- Convergent validity of the New Mobility Score (NMS) with other functional independence scales, cognitive status and age. [Time frame: Within 7 days following the fracture surgery]
- Predictive validity of mortality at postoperative day 30. [Time frame: Within 30 days following the fracture surgery]
- Discriminatory validity based on place of residence. [Time frame: Within 7 days following the fracture surgery]
Eligibility criteria
Inclusion criteria
- Patients aged 75 years and older admitted to a hospital department following a hip fracture and treated surgically (osteosynthesis or arthroplasty).
- Type of fracture: pertrochanteric fracture or femoral neck fracture.
- Sufficient proficiency in French to complete the questionnaires.
- Patients affiliated with a health insurance scheme.
- No objection to participate from the patient or the caregiver in case of cognitive impairment.
Exclusion Criteria: no exclusion criteria
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Service I3 de court séjour gériatrique, Hôpital de la Croix-Rousse, Hospices Civils de Lyo — Lyon
Identifiers
NCT: NCT07622095 · 69HCL25_0571